<DOC>
	<DOCNO>NCT00189254</DOCNO>
	<brief_summary>The purpose study obtain recurrence rate long-term safety data patient treat actinic keratoses face scalp 5 % Imiquimod Cream previous study .</brief_summary>
	<brief_title>A Study Follow Recurrence Rates Actinic Keratoses One Year After Completion Study 1487-IMIQ</brief_title>
	<detailed_description />
	<mesh_term>Recurrence</mesh_term>
	<mesh_term>Keratosis</mesh_term>
	<mesh_term>Keratosis , Actinic</mesh_term>
	<mesh_term>Imiquimod</mesh_term>
	<criteria>100 % clearance Actinic Keratosis ( AK ) lesion 1487 IMIQ study use treatment previous treatment area within 24 hour prior followup visit</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>1 year follow</keyword>
</DOC>